| Term 
 | Definition 
 
        | Parkinsons 
 dopamine precursor
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parkinsons 
 decarboxylase inhibitor (periphery)
 
 *response fluctuations "on-off"
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parkinsons 
 COMT inhibitor (periphery)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parkinsons 
 COMT inhibitor (brain & periphery)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parkinsons 
 dopamine agonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alzheimers 
 Ach esterase inhibitor
 
 (Aricept)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alzheimers 
 Ach esterase inhibitor
 
 (Exelon)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alzheimers 
 Ach esterase inhibitor
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alzheimers 
 glutamate NMDA inhibitor (block Ca+ channels)
 
 (Namenda)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ALS/Huntington's 
 (Lioresal)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antipsychotic 
 dopamine (D2) blocker (mesolimbic/mesocortical)
 
 AE: EPRs (parkinson effects) & tardive dyskinesia
 
 (Thorazine)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antipsychotic 
 dopamine (D2) blocker (mesolimbic/mesocortical)
 
 AE: EPRs (parkinson effects) & tardive dyskinesia
 
 (Navane)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antipsychotic 
 dopamine (D2) blocker (mesolimbic/mesocortical)
 
 AE: EPRs (parkinson effects) & tardive dyskinesia
 
 (Haldol)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antipsychotic 
 serotonin (5HT) blocker
 
 AE: no EPRs, but increases glucose & lipids
 
 (Geodon)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antipsychotic 
 serotonin (5HT) blocker
 
 AE: no EPRs, but increases glucose & lipids
 
 (Zyprexa)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antipsychotic 
 serotonin (5HT) blocker
 
 AE: no EPRs, but increases glucose & lipids
 
 (Risperidal)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antipsychotic 
 serotonin (5HT) blocker
 
 AE: no EPRs, but increases glucose & lipids
 
 (Clozanil)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antipsychotic 
 serotonin (5HT) blocker
 
 AE: no EPRs, but increases glucose & lipids
 
 (Abilify)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antipsychotic 
 serotonin (5HT) blocker
 
 AE: no EPRs, but increases glucose & lipids
 
 (Seroquel)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidepressant 
 Tricyclic
 
 AE: act on numerous other receptors
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidepressant 
 Tricyclic
 
 AE: act on numerous other receptors
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidepressant 
 SSRI
 
 (Zoloft)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidepressant 
 SSRI
 
 (Paxil)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidepressant 
 SSRI
 
 (Lexapro)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidepressant 
 SSRI
 
 (Prozac)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidepressant 
 SNRI
 
 (Effexor)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidepressant 
 MAOI
 
 AE: tyramine "cheese" effect causing HTN
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidepressant 
 MAOI
 
 AE: tyramine "cheese" effect causing HTN
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidepressant 
 MAOI
 
 AE: tyramine "cheese" effect causing HTN
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidepressant 
 (IP3 hydrolysis)(bipolar disorder)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Anxiety 
 benzo: bind GABA-a and increase Cl- influx
 
 (Librium)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Anxiety 
 benzo: bind GABA-a and increase Cl- influx
 
 (Serax)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Anxiety 
 benzo: bind GABA-a and increase Cl- influx
 
 (Ativan)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Anxiety 
 benzo: bind GABA-a and increase Cl- influx
 
 (Xanax)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Anxiety 
 benzo: bind GABA-a and increase Cl- influx
 
 (Valium)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Anxiety 
 for chronic anxiety (bc nonsedating/nonaddictive)
 
 (Buspar)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Anxiety 
 beta-blocker (stage freight)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Insomnia 
 melatonin agonist
 
 (Rozerem)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Insomnia 
 benzo agonist
 
 (Lunesta)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Insomnia 
 benzo agonist
 
 (Ambien)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Insomnia 
 benzo agonist
 
 (Sonata)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Seizures 
 Na+ blocker
 first line for generalized seizures
 
 AE: aplastic anemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Seizures 
 Na+ blocker
 
 AE: hirsutism, gingival hyperplasia
 
 *small therapeutic window
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Seizures 
 Ca+ blocker - absence seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Seizures 
 Ca+ blocker - absence seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PARTIAL opioid agonist (mu) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | opioid agonist 
 AE: respiratory depression
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | opioid antagonist 
 (treats addiction)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID (selective for COX-2) 
 no bleeding risk, but increased chance of stroke/MI
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Gout 
 anti-inflammatory (binds WBCs)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Gout 
 xanthine oxidase inhibitor
 (xanthine = precursor to uric acid)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Gout 
 block reabsorption of uric acid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Gout 
 block reabsorption of uric acid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Migraine 
 AE: aterial vasospasm
 
 triptans = serotonin agonists
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  |